Drug recall D-0407-2023
Product
Rosuvastatin Tablets, USP 40 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-287-10, UPC 3 16729 28710 4; b) 90-count bottle NDC 16729-287-15, UPC 3 16729 28715 9; c) 1,000-count bottle NDC 16729-287-17, UPC 3 16729 28717 3; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Reason for recall
CGMP Deviations: recalling drug products following an FDA inspection.
Lots and codes
Batches: a) P2100343, Exp. Date 12/31/2023; P2102371, Exp. Date 3/31/2024; b) P2101966, Exp. Date 2/28/2024; P2104545, Exp. Date 6/30/2024; P2204500, Exp. Date 7/31/2025; P2205415, Exp. Date 8/31/2025; c) P2101591, Exp. Date 2/28/2023; P2200062, Exp. Date 12/31/2024; P2204336, Exp. Date 7/31/2025; P2204337, Exp. Date 7/31/2025; P2205416, Exp. Date 8/31/2025;
Recall details
- Recalling firm
- Accord Healthcare, Inc., Durham, NC
- Quantity
- 102,360 bottles
- Distribution
- United States including Puerto Rico and Canada
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 7, 2023
- Terminated
- April 22, 2024
Related products
- Rosuvastatin – drug information
- NDC 16729-285 Rosuvastatin · Rosuvastatin Calcium 10 mg/1 · Accord Healthcare Inc.
- NDC 16729-286 Rosuvastatin · Rosuvastatin Calcium 20 mg/1 · Accord Healthcare Inc.
- NDC 16729-287 Rosuvastatin · Rosuvastatin Calcium 40 mg/1 · Accord Healthcare Inc.
- NDC 16729-284 Rosuvastatin · Rosuvastatin Calcium 5 mg/1 · Accord Healthcare Inc.